A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma

Cancer

Volumn 88, Issue 3, 2000, Pages 584-588

  Feun, Lynn G ^a   Savaraj, Niramol ^a   Hurley, Judith ^a   Marini, Angela ^a   Lai, Shenghan ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Efficacy; Melanoma; Tamoxifen; Toxicity; Vinorelbine tartrate

Indexed keywords

NAVELBINE; TAMOXIFEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FATIGUE; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MALE; MELANOMA; PARESTHESIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034141419     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(20000201)88:3<584::aid-cncr14>3.0.co;2-%23     Document Type: Article

References (30)

1. Balch CM, Reintgen DS, Kirkwood JM, Houghton A, Peters L, Ang KK, et al. Cutaneous melanoma. In: De Vita, VT Jr., Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott-Raven, 1997: 1947-94.
2. Deprete SA, Mauer LU, O'Donnell J, Forcier RJ, LeMarbe P. Combination chemotherapy with cisplatin, carmustine, dacarbazine and tamoxifen in metastatic melanoma. Cancer Treat Rep 1984;68:1403-5.
3. Saxman B, Meyers ML, Chapman PB, Destro AN, Pangenes KS, Begg CB, et al. A phase III multicenter randomized trial of DTIC, Cisplatin, BCNU, and Tamoxifen versus DTIC alone in patients with metastatic melanoma. Proc Am Soc Clin Oncol 1999;18:536a.
4. Lucas Donehower R, Rowinsky E, et al. Clinical results of a study of the absolute bioavailability (ABA) and pharmacokinetics (PK) of weekly Navelbine (NVB) liquid-filled soft gelatin capsules at full therapeutic doses in patients (pts) with solid tumors. Proc Am Soc Clin Oncol 1992;11:111.
5. Retsas S, Peat I, Ashford R, Coe M, Maher J, Drury A, et al. Updated results of vindesine as a single agent in therapy of advanced malignant melanoma. Cancer Treat Rev 1979; (Suppl)7:87-90.
6. Carmichael J, Atkinson RJ, Calman KC, Mackie RM, Naysmith AM, Smyth JF, et al. A multicenter phase II trial of vindesine in malignant melanoma. Eur J Cancer Clin Oncol 1982;18:1293-5.
7. DiBella NJ, Berris R, Garfield D, Fink K, Speer J, Sakamoto A. Vindesine in advanced breast cancer, lymphoma and melanoma. Invest New Drugs 1984;2(3):323-8.
8. Quagliana JM, Stephens RL, Baker LH, Costanzi JJ. Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study. J Clin Oncol 1984;2:316-9.
9. Nathanson L, Wittenberg BK. Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma. Cancer Treat Rep 1980;64:133-7.
10. Falkson G, Van Dyk JJ, Verwoerd HF. The chemotherapy of malignant melanoma. S Afr Med J 1968;42:89-90.
11. Gros S, Wright M, Morimoto M, Lataste H, Couzinier JP, Krikorian A. Experimental antitumor activity of Navelbine. Semin Oncol 1989;16(Suppl):15-20.
12. Nesbit RA, Woods RL, Tattersal MH, Fox RM, Forbes JF, MacKay IR, et al. Tamoxifen in malignant melanoma [letter]. N Engl J Med 1979;301:1241-2.
13. Reimer RR, Costanzi J, Fabian C. Southwest Oncology Group experience with tamoxifen in metastatic melanoma. Cancer Treat Rep 1982;66:1680-1.
14. Masiel A, Buttrick P, Bitran J. Tamoxifen in the treatment of malignant melanoma. Cancer Treat Rep 1981;65:531-2.
15. Meyskens FL Jr., Voakes JB. Tamoxifen in metastatic malignant melanoma. Cancer Treat Rep 1980;64:171-3.
16. Creagen ET, Ingle JN, Green SJ, Ahmann DL, Jiang NS. Phase II study of tamoxifen in patients with disseminated malignant melanoma. Cancer Treat Rep 1980;64:199-201.
17. Rumke P, Kleeberg UR, MacKie RM, Lejeune FJ, Planting AS, Brocker EB, et al. Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC malignant melanoma cooperative group. Melanoma Res 1992;2:153-5.
18. Cocconi G, Bella M, Calabresi F, Tonato M, Canaletti R, Boni C, et al. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. N Engl J Med 1992;327:516-23.
19. McClay EF, Albright KD, Jones JA, Christen RD, Howell SB. Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells. Cancer Res 1993;53:1571-6.
20. McClay EF, McClay ME. Tamoxifen: is it useful in the treatment of patients with metastatic melanoma? J Clin Oncol 1994;12:617-26.
21. McClay EF, Mastrangelo MJ, Bellet RE, Berd D. The importance of Tamoxifen to a cisplatin containing regimen in the treatment of malignant melanoma. Cancer 1989;63:1292-5.
22. Buzaid AL, Murren JR, Durivage HJ. High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma. Cancer 1991;68:1238-41.
23. Rusthoven JJ, Quirt IC, Iscoe NA, McCulloch PB, James KW, Reinhard C, et al. Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine and cisplatin with and without tamoxifen in patients with metastatic melanoma. J Clin Oncol 1996;14: 2083-90.
24. Creagan ET, Suman VJ, Dalton RJ, Pitot H, Long HJ, Veeder MH, et al. Phase III clinical trials of the combination of cisplatin, dacarbazine and carmustine with or without tamoxifen in patients with advanced malignant melanoma. J Clin Oncol 1999;17:1884-90.
25. Fisher RI, Neifeld JP, Lippman ME. Estrogen receptors in human malignant melanoma. Lancet 1976;2:337-8.
26. Jacquillat C, Khayat D, Banzet P, Weil M, Fumoleau P, Avril MF, et al. Final report of the French multicenter phase II study of the nitrosourea Fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases. Cancer 1990;66:1873-8.
27. Al-Sarraf M, Fletcher W, Oishi N, Pugh R, Hewlett JS, Balducci L, et al. Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a Southwest Oncology Group Study. Cancer Treat Rep 1982; 66:31-5.
28. Feun LG, Gonzales R, Savaraj N, Hanlon J, Collier M, Robinson WA, et al. Phase II trial of piritrexim (301u, PTX) capsules in metastatic melanoma using prolonged, low-dose administration. J Clin Oncol 1991;9:464-7.
29. Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, et al. Treatment of uveal melanoma metastatic to the liver. Cancer 1995;76:1665-70.
30. Margolin KA, Liu PY, Flaherty LE, Sosman JA, Walker MJ, Smyth JW, et al. Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group Study. J Clin Oncol 1998;16:664-9.